Literature DB >> 18167453

Inhibition of proinflammatory cytokine-induced invasiveness of HT-29 cells by chitosan oligosaccharide.

Kyung-Soo Nam1, Mee-Kyung Kim, Yun-Hee Shon.   

Abstract

The effect of chitosan oligosaccharide (COS, 1 kDa <MW<3 kDa) on proinflammatory cytokines-induced nitric oxide (NO) production and invasiveness of human colorectal adenocarcinoma HT-29 cells was investigated. COS (0.1-5mg/ ml) suppressed the NO production induced by proinflammatory cytokines (100 U/ml IFN-gamma, 10 ng/ml IL-1alpha, and 25 ng/ml TNF-alpha) in HT-29 cells. Inducible nitric oxide synthase (iNOS) expression induced by these cytokines was inhibited by COS. COS pretreatment inhibited the invasiveness of cytokines-treated HT-29 cells through Matrigel-coated membrane in a dose-dependent manner. COS also inhibited cytokines-induced matrix metalloproteinase (MMP)-2 activity. This study shows that proinflammatory cytokines induce NO production, iNOS expression, and invasiveness of human colorectal adenocarcinoma HT-29 cells. COS pretreatment inhibited cytokines-mediated NO production, iNOS expression, and invasiveness of HT-29 cells. These results provide sufficient information for the further development of COS as an antitumor metastatic agent for the treatment of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18167453

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  11 in total

Review 1.  Production of chitooligosaccharides and their potential applications in medicine.

Authors:  Berit B Aam; Ellinor B Heggset; Anne Line Norberg; Morten Sørlie; Kjell M Vårum; Vincent G H Eijsink
Journal:  Mar Drugs       Date:  2010-04-27       Impact factor: 5.118

2.  Endotoxins affect diverse biological activity of chitosans in matters of hemocompatibility and cytocompatibility.

Authors:  Andrea Nolte; Susanne Hossfeld; Marcell Post; Jan Niederlaender; Tobias Walker; Christian Schlensak; Hans Peter Wendel
Journal:  J Mater Sci Mater Med       Date:  2014-05-31       Impact factor: 3.896

3.  Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release.

Authors:  Gaurav Bajaj; William G Van Alstine; Yoon Yeo
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

4.  Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes.

Authors:  Frederic Oprenyeszk; Christelle Sanchez; Jean-Emile Dubuc; Véronique Maquet; Catherine Henrist; Philippe Compère; Yves Henrotin
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

Review 5.  Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides.

Authors:  Kazuo Azuma; Tomohiro Osaki; Saburo Minami; Yoshiharu Okamoto
Journal:  J Funct Biomater       Date:  2015-01-14

Review 6.  A Review of the Preparation, Analysis and Biological Functions of Chitooligosaccharide.

Authors:  Shuang Liang; Yaxuan Sun; Xueling Dai
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

Review 7.  Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action.

Authors:  Hari Sharan Adhikari; Paras Nath Yadav
Journal:  Int J Biomater       Date:  2018-12-30

Review 8.  Beyond Heat Stress: Intestinal Integrity Disruption and Mechanism-Based Intervention Strategies.

Authors:  Puqiao Lian; Saskia Braber; Johan Garssen; Harry J Wichers; Gert Folkerts; Johanna Fink-Gremmels; Soheil Varasteh
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717

Review 9.  The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis.

Authors:  Zahra Chegini; Mojtaba Didehdar; Amin Khoshbayan; Jafar Karami; Milad Yousefimashouf; Aref Shariati
Journal:  Cell Commun Signal       Date:  2022-03-09       Impact factor: 5.712

10.  Influence of glucosamine on the bioactivity of insulin delivered subcutaneously and in an oral nanodelivery system.

Authors:  Zakieh I Al-Kurdi; Babur Z Chowdhry; Stephen A Leharne; Nidal A Qinna; Mahmoud M H Al Omari; Adnan A Badwan
Journal:  Drug Des Devel Ther       Date:  2015-11-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.